<ul>
<li>Option Care Health, Inc. 之前因患者留存率下降和治疗组合变化下调了 2026 年的指引，这引发了多项证券法调查，并对其近期前景提出了质疑。</li>
<li>与此同时，内部人士的股票购买和高层领导即将举行的会议评论为投资者评估公司的未来方向增添了额外的背景信息。</li>
<li>由于指引修订与患者留存率下降和治疗组合变化相关，我们将探讨这一发展如何重塑 Option Care Health 的投资叙事。</li>
</ul>
<p>人工智能即将改变医疗保健。这 32 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<h2>Option Care Health 投资叙事回顾</h2>
<p>要拥有 Option Care Health，您需要相信其家庭和替代场所输液模式能够在治疗组合变化和患者留存率下降的压力下保持韧性。目前，短期内的关键催化剂是管理层在 2026 年指引下调后能多快稳定留存率和治疗组合，而最大风险是这些趋势持续存在并继续压缩利润率。最近的律师事务所调查突显了这种不确定性，但并不会单独改变运营基本面。</p>
<p>最近最相关的发展是 2026 年指引的修订，预计净收入削减至 57.675 亿至 57.775 亿美元，因留存率和治疗组合下降，导致股价下跌 26.4%。在这种背景下，首席执行官和首席财务官在美国银行全球医疗会议上的即将评论显得尤为重要，因为这可能会阐明领导层如何计划重建慢性病量和管理支付方及治疗组合风险，这现在是短期表现的核心焦点。</p>
<p>然而，在内部人士购买和指引重置的背后，治疗组合变化带来的持续利润压力风险仍然是投资者需要关注的...</p>
<p>阅读关于 Option Care Health 的完整叙事（免费！）</p>
<p>Option Care Health 的叙事预计到 2029 年收入为 69 亿美元，收益为 3.029 亿美元。</p>
<p>揭示 Option Care Health 的预测如何得出 30.73 美元的公允价值，相较于当前价格有 57% 的上涨空间。</p>
<h2>探索其他视角</h2>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9aac0566-8088-48b7-9e98-e2064f7c1608/chart/quote-price?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9aac0566-8088-48b7-9e98-e2064f7c1608/chart/quote-price"/></p>
<p>OPCH 1 年股票价格走势图</p>
<p>在此消息之前，最悲观的分析师已经假设年收入增长仅约 5.9%，到 2029 年大约为 67 亿美元，并将诊所建设成本视为利润的主要制约因素，这提醒您对 Option Care Health 的看法可能会有很大差异，并可能需要在留存率和组合数据演变时重新考虑。</p>
<p>探索关于 Option Care Health 的另外两个公允价值估计——为什么该股票可能比当前价格高出 57%！</p>
<h2>形成您自己的判断</h2>
<p>不同意现有叙事？非凡的投资回报很少来自随大流，因此请遵循您的直觉。</p>
<ul>
<li>开始您对 Option Care Health 研究的一个很好的起点是我们的分析，突出了 3 个关键收益和 1 个可能影响您投资决策的重要警示信号。</li>
<li>我们的免费 Option Care Health 研究报告提供了全面的基本面分析，汇总在一个视觉图中——雪花图，使您能够一目了然地评估 Option Care Health 的整体财务健康状况。</li>
</ul>
<h2>寻找替代机会？</h2>
<p>我们的每日扫描揭示了具有突破潜力的股票。不要错过这个机会：</p>
<ul>
<li>揭示下一个大事件，27 只精英便士股票在风险与回报之间取得平衡。</li>
<li>超越巨头：这 16 只早期阶段的人工智能股票可能为您的退休提供资金。</li>
<li>工作的未来已经到来。发现 33 只在人工智能驱动的自动化和工业转型中引领潮流的顶级机器人和自动化股票。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<h3><strong>新：</strong> AI 股票筛选器和提醒</h3>
<p>我们的新 AI 股票筛选器每天扫描市场以发现机会。</p>
<p>• 分红强劲的股票（收益率 3% 以上）</p>
<p>• 具有内部人士购买的被低估小盘股</p>
<p>• 高增长的科技和人工智能公司</p>
<p>或从 50 多个指标中构建您自己的筛选器。</p>
<p>立即免费探索</p>

拜尔斯普保健

美国医疗保健供应商 ETF - iShares

医疗业 ETF - Vanguard

标普全球医疗股指数 ETF - iShares

标普医疗保健服务 ETF - SPDR

医疗业 ETF - SPDR

<p>Option Care Health, Inc. 将其 2026 年的收入指引下调至 57.5 亿至 57.75 亿美元，原因是患者留存率和治疗组合较弱，导致股价下跌 26.4%。内部人士的买入和即将发布的管理层评论可能会为稳定这些问题提供见解。分析师预计该股当前价格有潜在 57% 的上涨空间，但仍存在持续的利润压力风险。投资者被鼓励评估公司的财务健康状况，并考虑其他投资机会</p>

<ul>
<li>Option Care Health, Inc. previously cut its 2026 guidance due to weaker patient retention and a changed therapy mix, prompting multiple securities law investigations and raising questions about its recent outlook.</li>
<li>At the same time, insider share purchases and upcoming conference commentary from senior leadership add an extra layer of context for investors assessing the company’s future direction.</li>
<li>With the guidance revision tied to weaker patient retention and therapy mix, we’ll examine how this development reshapes Option Care Health’s investment narrative.</li>
</ul>
<div class="lb-trans"><ul>
<li>Option Care Health, Inc. 之前因患者留存率下降和治疗组合变化下调了 2026 年的指引，这引发了多项证券法调查，并对其近期前景提出了质疑。</li>
<li>与此同时，内部人士的股票购买和高层领导即将举行的会议评论为投资者评估公司的未来方向增添了额外的背景信息。</li>
<li>由于指引修订与患者留存率下降和治疗组合变化相关，我们将探讨这一发展如何重塑 Option Care Health 的投资叙事。</li>
</ul>
</div><p>AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 32 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><h2>Option Care Health Investment Narrative Recap</h2>
<div class="lb-trans"><h2>Option Care Health 投资叙事回顾</h2>
</div><p>To own Option Care Health, you need to believe its home and alternate site infusion model can remain resilient despite pressure from shifting therapy mix and softer patient retention. Right now, the key short term catalyst is how quickly management can stabilize retention and mix after the 2026 guidance cut, while the biggest risk is that these trends linger and keep compressing margins. The recent law firm investigations highlight this uncertainty but do not, by themselves, change the operating fundamentals.</p>
<div class="lb-trans"><p>要拥有 Option Care Health，您需要相信其家庭和替代场所输液模式能够在治疗组合变化和患者留存率下降的压力下保持韧性。目前，短期内的关键催化剂是管理层在 2026 年指引下调后能多快稳定留存率和治疗组合，而最大风险是这些趋势持续存在并继续压缩利润率。最近的律师事务所调查突显了这种不确定性，但并不会单独改变运营基本面。</p>
</div><p>The most relevant recent development is the 2026 guidance revision, which trims expected net revenue to US$5.675–5.775 billion after weaker retention and mix, and triggered a 26.4% share price drop. In that context, upcoming commentary from the CEO and CFO at the Bank of America Global Healthcare Conference matters, as it may clarify how leadership plans to rebuild chronic volumes and manage payer and therapy mix risk, now a central focus for near term performance.</p>
<div class="lb-trans"><p>最近最相关的发展是 2026 年指引的修订，预计净收入削减至 57.675 亿至 57.775 亿美元，因留存率和治疗组合下降，导致股价下跌 26.4%。在这种背景下，首席执行官和首席财务官在美国银行全球医疗会议上的即将评论显得尤为重要，因为这可能会阐明领导层如何计划重建慢性病量和管理支付方及治疗组合风险，这现在是短期表现的核心焦点。</p>
</div><p>Yet beneath the insider buying and guidance reset, one risk around sustained margin pressure from therapy mix shifts remains something investors should be aware of...</p>
<div class="lb-trans"><p>然而，在内部人士购买和指引重置的背后，治疗组合变化带来的持续利润压力风险仍然是投资者需要关注的...</p>
</div><p>Read the full narrative on Option Care Health (it's free!)</p>
<div class="lb-trans"><p>阅读关于 Option Care Health 的完整叙事（免费！）</p>
</div><p>Option Care Health's narrative projects $6.9 billion revenue and $302.9 million earnings by 2029.</p>
<div class="lb-trans"><p>Option Care Health 的叙事预计到 2029 年收入为 69 亿美元，收益为 3.029 亿美元。</p>
</div><p>Uncover how Option Care Health's forecasts yield a $30.73 fair value, a 57% upside to its current price.</p>
<div class="lb-trans"><p>揭示 Option Care Health 的预测如何得出 30.73 美元的公允价值，相较于当前价格有 57% 的上涨空间。</p>
</div><h2>Exploring Other Perspectives</h2>
<div class="lb-trans"><h2>探索其他视角</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9aac0566-8088-48b7-9e98-e2064f7c1608/chart/quote-price" alt="" original-src="https://images.simplywall.st/company/9aac0566-8088-48b7-9e98-e2064f7c1608/chart/quote-price"/></p>
<p>OPCH 1-Year Stock Price Chart</p>
<div class="lb-trans"><p>OPCH 1 年股票价格走势图</p>
</div><p>Before this news, the most pessimistic analysts already assumed only about 5.9% annual revenue growth to roughly US$6.7 billion by 2029 and saw clinic build out costs as a key brake on margins, reminding you that views on Option Care Health can differ sharply and may need reconsidering as retention and mix data evolve.</p>
<div class="lb-trans"><p>在此消息之前，最悲观的分析师已经假设年收入增长仅约 5.9%，到 2029 年大约为 67 亿美元，并将诊所建设成本视为利润的主要制约因素，这提醒您对 Option Care Health 的看法可能会有很大差异，并可能需要在留存率和组合数据演变时重新考虑。</p>
</div><p>Explore 2 other fair value estimates on Option Care Health - why the stock might be worth as much as 57% more than the current price!</p>
<div class="lb-trans"><p>探索关于 Option Care Health 的另外两个公允价值估计——为什么该股票可能比当前价格高出 57%！</p>
</div><h2>Form Your Own Verdict</h2>
<div class="lb-trans"><h2>形成您自己的判断</h2>
</div><p>Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.</p>
<div class="lb-trans"><p>不同意现有叙事？非凡的投资回报很少来自随大流，因此请遵循您的直觉。</p>
</div><ul>
<li>A great starting point for your Option Care Health research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.</li>
<li>Our free Option Care Health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Option Care Health's overall financial health at a glance.</li>
</ul>
<div class="lb-trans"><ul>
<li>开始您对 Option Care Health 研究的一个很好的起点是我们的分析，突出了 3 个关键收益和 1 个可能影响您投资决策的重要警示信号。</li>
<li>我们的免费 Option Care Health 研究报告提供了全面的基本面分析，汇总在一个视觉图中——雪花图，使您能够一目了然地评估 Option Care Health 的整体财务健康状况。</li>
</ul>
</div><h2>Looking For Alternative Opportunities?</h2>
<div class="lb-trans"><h2>寻找替代机会？</h2>
</div><p>Our daily scans reveal stocks with breakout potential. Don't miss this chance:</p>
<div class="lb-trans"><p>我们的每日扫描揭示了具有突破潜力的股票。不要错过这个机会：</p>
</div><ul>
<li>Uncover the next big thing with 27 elite penny stocks that balance risk and reward.</li>
<li>Outshine the giants: these 16 early-stage AI stocks could fund your retirement.</li>
<li>The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.</li>
</ul>
<div class="lb-trans"><ul>
<li>揭示下一个大事件，27 只精英便士股票在风险与回报之间取得平衡。</li>
<li>超越巨头：这 16 只早期阶段的人工智能股票可能为您的退休提供资金。</li>
<li>工作的未来已经到来。发现 33 只在人工智能驱动的自动化和工业转型中引领潮流的顶级机器人和自动化股票。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><h3><strong>New:</strong> AI Stock Screener &amp; Alerts</h3>
<div class="lb-trans"><h3><strong>新：</strong> AI 股票筛选器和提醒</h3>
</div><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p>
<div class="lb-trans"><p>我们的新 AI 股票筛选器每天扫描市场以发现机会。</p>
</div><p>• Dividend Powerhouses (3%+ Yield)</p>
<div class="lb-trans"><p>• 分红强劲的股票（收益率 3% 以上）</p>
</div><p>• Undervalued Small Caps with Insider Buying</p>
<div class="lb-trans"><p>• 具有内部人士购买的被低估小盘股</p>
</div><p>• High growth Tech and AI Companies</p>
<div class="lb-trans"><p>• 高增长的科技和人工智能公司</p>
</div><p>Or build your own from over 50 metrics.</p>
<div class="lb-trans"><p>或从 50 多个指标中构建您自己的筛选器。</p>
</div><p>Explore Now for Free</p>
<div class="lb-trans"><p>立即免费探索</p>
</div>

What Option Care Health (OPCH)'s Guidance Cut and Insider Buying Signal Means For Shareholders

Simplywall

美国银行

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

拜尔斯普保健（OPCH）指导下调和内部购买信号对股东的意义是什么